Clinical Trials Directory

Trials / Sponsors / X4 Pharmaceuticals

X4 Pharmaceuticals

Industry · 12 registered clinical trials — 2 currently recruiting.

StatusTrialPhaseStarted
RecruitingA Study to Investigate Pharmacokinetics (PK) and Safety of a Single Dose of Mavorixafor in Participants With H
Hepatic Insufficiency
Phase 12025-02-28
CompletedDrug-Drug Interaction Potential of Mavorixafor
Healthy Participants
Phase 12025-02-18
RecruitingA Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic
Neutropenia
Phase 32024-06-06
CompletedA Study of Mavorixafor in Participants With Congenital Neutropenia and Chronic Idiopathic Neutropenia Disorder
Neutropenia
Phase 1 / Phase 22021-10-16
CompletedA Study of Mavorixafor in Combination With Ibrutinib in Participants With Waldenstrom's Macroglobulinemia (WM)
Waldenstrom's Macroglobulinemia
Phase 12020-04-30
Active Not RecruitingEfficacy and Safety Study of Mavorixafor in Participants With Warts, Hypogammaglobulinemia, Infections, and My
WHIM Syndrome
Phase 32019-10-24
WithdrawnA Retrospective and Prospective Natural History Study of Patients With WHIM Syndrome
WHIM Syndrome
—2018-06-01
TerminatedAddition of X4P-001 to Nivolumab Treatment in Participants With Renal Cell Carcinoma
Clear Cell Renal Cell Carcinoma
Phase 1 / Phase 22016-12-07
CompletedA Dose Determination and Safety Study of X4P-001 (Mavorixafor) in Participants With Warts, Hypogammaglobulinem
WHIM Syndrome
Phase 22016-12-01
CompletedX4P-001 and Pembrolizumab in Patients With Advanced Melanoma
Melanoma
Phase 12016-09-15
CompletedTrial of X4P-001 in Participants With Advanced Renal Cell Carcinoma
Clear Cell Renal Cell Carcinoma
Phase 1 / Phase 22016-04-27
TerminatedA Study Comparing Once-Daily vs. Twice-Daily Dosing of X4P-001 in Healthy Volunteers
Healthy
Phase 12016-01-12